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Summary 
In mice double transgenic for functionally rearranged  T  cell receptor (TCR) VB2 and V~8.2 
genes we found that  most T  lymphocytes express both TCR/3 chains simultaneously.  These 
T cells show no abnormality in thymic selection in vivo and their TCRs are capable of transducing 
activation  signals in vitro.  These results indicate that  multispecific T  cells  may appear in the 
periphery if allelic exclusion of TCR/3 genes is not established at the level of gene rearrangement. 
ntigen receptors of T lymphocytes are clonally expressed, 
i.e.,  all  receptors expressed on  the surface of a given 
T  cell are identical.  Clonal expression of TCR may be im- 
portant to avoid autoreactivity and to achieve efficient thymic 
selection of functional T cells. Clonal expression is controlled 
by a process called allelic  exclusion. Using transgenic mice 
carrying functionally rearranged  TCR ~/genes it has been 
shown that  allelic  exclusion is a regulated event (references 
1-4; van Meerwijk, J. P. M., A. Iglesias,  T. Hansen:Hagge, 
H. Bluethmann,  and M. Steinmetz,  manuscript  submitted 
for publication; Iglesias, A., T. Hansen-Hagge, A. yon Bonin, 
and H. U. Weltzien, manuscript submitted for publication). 
In the presence of a functionally rearranged  TCR B trans- 
gene, VB gene segment rearrangements  at the endogenous 
loci are suppressed and thus only the transgenic  ~/chain is 
expressed.  In contrast,  the presence of a functionally rear- 
ranged TCR oe transgene  does not block endogenous Vo~ 
rearrangement  (2, 5). Thus, different mechanisms appear to 
establish  allelic  exclusion in TCR c~ and/3  genes. 
Is allelic exclusion of TCR/3 genes controlled exclusively 
at the level of gene rearrangement,  or is there a fail-safe mech- 
anism operating  in vivo to prevent T  cells  expressing two 
different receptors to accumulate in the periphery? We have 
investigated whether T cells with two productively rearranged 
TCR/3 genes can express two functional/3 chains simultane- 
ously in vivo. 
Materials and Methods 
Mice.  TCR V~8.2 transgenic mice (3), backcrossed with strain 
C57BL/6 (H-2b), were crossed with TCR V~82 transgenic mice 
(Iglesias,  A.,  manuscript  in  preparation)  of H-2  bd  haplotype. 
Offspring was analysed at the age of 4 wk. No significant differ- 
ence in  experimental  results  was observed between H-2  bb and 
H-2  ~  pups (data not shown). 
Cytofluorimetric Analyses.  Thymus  and  lymphnodes  were 
homogenized,  cells were  recovered and  washed  twice in  PBS/ 
5 %FCS/0.1%NaN3. IgG-positive B lymphocytes were eliminated 
from the lymphnode  cell preparation as described elsewhere (van 
Meerwijk, J.P.M., A. Iglesias, T. Hansen-Hagge,  H. Bluethmann, 
and M. Steinmetz, manuscript  submitted for publication). T cells 
were stained with the following antibodies: biotinylated anti-mouse 
VB2 (B20.6.5; reference 21) and anti-mouse V~88 (F23.1, reference 
6) as described previously (7). As secondary reagents FITC-labeled 
anti-mouse Ig (Silenus Laboratories, LTD,, Victoria, Australia) and 
streptavidin-PE  (Southern  Biotechnology  Associates, Inc.,  Bir- 
mingham, AL) were used. Anti-mouse CD4-PE (L3T4) and CDB- 
FITC (Lyt-2) are from Becton Dickinson and Co. (Mountain View, 
CA). List mode data were processed using FACScan research soft- 
ware (Becton Dickinson  and Co.) and displayed as dot-plots  (log 
scale). 
Immobilized Antibody  Assays.  Flat-bottom  microtiter  plates 
(Nunc immunoplate)  were incubated with  10/~g/ml goat anti- 
mouse Ig or goat anti-rat Ig (Southern Biotechnology Associates, 
Inc.) for 2 h at 37~  Wells were then washed with PBS plus 10% 
FCS and subsequentally coated with dilutions  of supernatant  of 
hybridoma culture of B20.6.5, F23.1, or 145-2CII, for 2 h at 37~ 
After washing, 5  x  104 lymphnode  cells were plated per well in 
Iscove medium plus 10% FCS. [3H]thymidine incorporation  was 
measured 40 h later. 
In vitro Staphylococcal Enterotoxin B (SEB) Stimulation.  0.5  x 
10  ~ lymphnode cells were cocultured with 106 irradiated syngeneic 
spleen cells in 0.2 ml complete medium with SEB (100, 10, 1 ng/ml) 
or without. [3H]thymidine incorporation was measured 48 h later. 
Mixed Lymphocyte Reactions.  0.5  x  106 lymph node cells from 
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in triplicate with 106 irradiated  syngeneic  or aUogeneic  H-2  s spleen 
cells. [3H]thymidine  incorporation was measured 48 h later. 
Table  1.  Number of Thymocytes in Nontransgenic and T  Cell 
Receptor V~2/Vf18.2 Double Transgenic Mice (TgVB2/V~8.2) 
at Different Ages 
Results and Discussion 
We crossed mice transgenic for a functionally rearranged 
V38.2 gene (3) with mice transgenic for a functionally rear- 
ranged V32 gene (van Meerwijk, J. P. M., A. Iglesias, T. 
Hansen-Hagge, H. Bluethmann, and M. Steinmetz, manu- 
script  submitted for publication;  Iglesias, A.,  T.  Hansen- 
Hagge, A. yon Bonin, and H. U. Wehzien, manuscript sub- 
mitted for publication).  Double transgenic mice as well as 
single- and nontransgenic littermates  were analyzed for ex- 
pression of the V38.2 and V~2 transgenes in thymocytes and 
peripheral  T  lymphocytes. 
As  compared  to  nontransgenic  mice  (nTg)  1 and  mice 
single transgenic for the V/~2 (TgV/~2) or VB8.2 (TgV38.2) 
gene, the thymuses of V32/V/~8.2 double transgenic litter- 
mates (TgV/~2/V/~8.2) are significantly smaller. The differ- 
ence in size is most striking at 6 wk-of-age (Table 1). 
As shown in Fig. I a thymocytes from mice single trans- 
genic for the functionally rearranged  TCR V/32 or V~8.2 
genes express the transgene at both low and high levels cor- 
responding to immature and mature thymocytes, respectively. 
Thymocytes derived from TgVB2/VB8.2  double transgenic 
mice express the products of both transgenes on the cell sur- 
face simultaneously  (Fig.  1 a). 
To find out whether thymocytes expressing two different 
TCRs simultaneously  can make their way through thymic 
selection to the peripheral  lymphoid organs,  we examined 
lymphnode T cells for expression of Vfl2 and Vfl8 transgenes 
(Fig. 1 b). Mice single transgenic for the TCR VB2 or V/38.2 
gene express only the transgenic/~ chain at high levels on 
>95%  of peripheral  T  lymphocytes.  Interestingly,  periph- 
eral T lymphocytes of TgV32/VB8.2 double transgenic mice 
express both transgenic B chains simultaneously  (Fig. 1 b). 
The V{32/VB8 staining pattern shows that not all cells ex- 
press equivalent densities of V/~2 and VB8.2 chains. About 
one third of the peripheral T lymphocytes carry slightly lower 
levels of VB8.2 than V/32 (population 1, Fig. 1 b), one third 
display equal amounts of VB2 and V/~8 (population 2) and 
one third display less V32 than V/~8.2 (population 3). The 
variation in surface expression may be due to different pairing 
efficiencies of the two transgenic ~ chains with the different 
endogenous c~ chains. Variable surface expression of transfected 
pairs of TCR c~ and 3  chains was observed previously (8). 
As far as the CD4/CD8  staining  pattern is concerned, 
thymocytes and peripheral T lymphocytes of TgVB2/V38.2 
double transgenic  mice are not significantly different from 
their single transgenic counterparts and the non-transgenic 
controls (Table 2). 
The TCRs on peripheral T lymphocytes of TgVB2/V38.2 
double transgenic mice and single- and nontransgenic litter- 
mates were examined for their ability to transduce T cell ac- 
Abbreviation used in this paper: nTg, nontransgenic. 
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Figure 1.  TCR V32 and V38.2  expression on thymocytes (.4) and 
lymphnode T lymphocytes (B) from nontransgenic (nTg), V/32 (TgVB2), 
V38.2 (TgV38.2) and VI32/V/38.2 (TgVB2/V/38.2) transgenic mice. Boxes 
in Fig. 1 b correspond to populations 1, 2, and 3 as mentioned in the 
text and legend to Fig. 3 b. 
816  AUelic  Exclusion at DNA Rearrangement Level Is Required Table 2.  CD4/CD8  Phenotype of Transgenic and Nontransgenic Thyraocytes and Peripheral T Lymyhocytes 
Genotype  Cells  CD4-CD8-  CD4 +CD8-  CD4-CD8 +  CD4 §  + 
nTg 
TgVfl2 
TgVfl8.2 
TgVfl2/VflS.2 
nTg 
TgVfl2 
TgVfl8.2 
TgVfl2/Vfl8.2 
Thymocytes  8  9  3  80 
10  12  4  73 
15  13  3  68 
7  11  6  76 
Lymphnode  3  60  36  1 
T  cells  4  54  41  1 
2  71  26  1 
7  54  38  1 
Populations  are given as percentages  of total. 
tivation signals in vitro using immobilized antibody assays, 
mixed lymphocyte reactions and superantigen  stimulation. 
It was shown previously that T cells can be activated with 
immobilized antibodies specific for different components of 
the TCR (9). Using antibodies specific for Vfl8 (F23.1) and 
Vfl2 (B20.6.5)  we could differentially induce proliferation 
of peripheral T lymphocytes of mice transgenic for the Vfl8 
or Vfl2 gene, respectively (Fig. 2 a). Peripheral T lympho- 
cytes of TgVB2/Vf18.2 mice were readily stimulated using 
immobilized antibodies specific for Vfl2, Vfl8 and CD3 and 
with a combination of anti-Vfl2 and anti-V38 antibodies (Fig. 
2 a). 
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Fig,,re 2.  Lymphocytes expressing two different TCRs can be activated 
in vitro.  (.4) Responses of lymphnode cells from nTg, TgVfl2, TgVflS.2 
and TgVf12/V38.2 mice  to  immobilized  antibodies  specific for Vfl2 
(B2X).6.5) (I), V38.2 (F23.1) (F-l), Vfl2/Vfl8.2 (A) and CD3e (145-2CII) 
(A). (B) Responses of lymphnode cells from nTg (11), TgVfl2 (F1), TgVfl8.2 
(&) and TgVfl2/Vfl8.2  (A) mice to Staphylococcal enterotoxin B (SEB). 
(C)  Mixed  lymphocyte reaction.  Lymphnode cells from nTg, TgVfl2, 
TgVfl8.2 and TgVfl2/Vfl8.2  mice were co-cultured with irradiated syn- 
geneic (F-l) or allogeneic (n)  spleen cells. 
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The stimulated ceils were analyzed by flow cytometry. The 
changes in forward (FSC) and side scatter (SSC) patterns were 
taken as criterion for activation (see legend to Fig. 3 a). Cells 
carrying both Vfl2 and Vf18.2 chains at similar levels (popu- 
lation 2) are stimulated in all arrays, as are the cells displaying 
less Vf18.2 than Vfl2 (population 1, Fig. 3 b). The popula- 
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Figure 3.  Stimulation of different double transgenic lymphocyte popu- 
lations. (A) Stimulation by immobilized antibodies leads to increased for- 
ward (FSC) and side scatter (SSC) as shown for TgVfl2 cells stimulated 
by anti-Vfl2 antibody (TgVfl2, anti-Vfl2, see Fig. 2 A for thymidine incor- 
poration data). As negauve control the FSC/SSC pattern of TgVflS.2 cells 
incubated  in the presence of immobilized  anti-Vfl2 antibody is shown 
(TgVfl8, anti-Vfl2). FSC is a measure for cell-size and SSC for granularity. 
(B) FSC/SSC patterns of the three double transgenic (TgVfl2/Vfl8.2)  T 
lymphocyte populations after several stimulations.  Populations  1, 2, and 
3 are as indicated in Fig. 1 B. Stimulations were as indicated in the figure. tion displaying less Vfl2 than Vf18.2 chains (population 3) 
is not stimulated by the Vfl2 antibody (Fig.  3 b), whereas 
there is no obvious difference in stimulation of this popula- 
tion by the other antibodies. These results indicate that both 
the Vfl2 and Vf18.2 TCRs are capable of transducing activa- 
tion signals in vitro. The observation that practically all cells 
carrying similar levels of Vfl2 and Vf18.2 are stimulated by 
Vfl2 and Vfl8 antibodies (Fig. 3 b), suggests that both TCRs 
are functional on the same cell. 
The superantigen staphylococcal enterotoxin B  (SEB) is 
known to activate murine T  cells carrying Vfl8 chains (for 
review see reference 10). Proliferation of T cells from Vf18.2 
single transgenic mice and from Vfl2/Vfl8.2 double trans- 
genic littermates was observed (Fig. 2 b). T lymphocytes from 
Vfl2 transgenic mice did not respond,  as expected. Flow 
cytometry analysis showed that the population expressing high 
levels of Vfl2 and V~8,2 simultaneously and the one displaying 
high levels of Vf18.2 but lower levels of Vfl2 were both stimu- 
lated (data not shown). 
Peripheral T lymphocytes from nTg, TgVfl2, TgVfl8.2 and 
TgVfl2/Vfl8.2 mice were also examined for alloreactivity. T 
lymphocytes from all mice responded to allogeneic stimu- 
lator cells (Fig. 2 c). No significant differences in the responses 
of the three above mentioned populations in double trans- 
genic mice were observed in flow cytometry analysis  (data 
not shown). 
Our results with mice double transgenic for functionally 
rearranged Vfl2 and Vf18.2 transgenes show that thymocytes 
in these mice expressed both transgenic fl chains on their 
surface.  Surprisingly,  thymocytes expressing two different 
TCRs simultaneously were able to make their way through 
thymic selection to peripheral lymphoid organs. Moreover, 
peripheral T  lymphocytes expressing both fl chains on the 
cell surface were able to respond to stimulation by immobi- 
lized antibodies, superantigens and allogeneic stimulator ceils. 
Thus, T lymphocytes expressing two different TCRs on their 
surface can be selected in vivo and are functional at least in 
vitro. Therefore, clonal expression of TCRs in vivo requires 
allelic exclusion of TCR fl genes to be achieved at the level 
of gene rearrangement. 
In contrast, alMic exclusion of TCR ot genes, appears to 
be established primarily at a level after gene rearrangement 
(2, 5, 11). Posttranscriptional  mechanisms, (12), such as pairing 
of a  and fl chains (8), or thymic selection may play a role. 
Our data indicate that these, or other post'rearrangement mech- 
anisms cannot ensure allelic exclusion of TCR fl genes. 
A1Mic exclusion of Ig genes in B cells seem to be very 
similarly controlled as that of TCR genes in T  cells. Func- 
tionally rearranged Ig H  chain genes were found to inhibit 
gene rearrangement of the endogenous Ig H  loci at the V. 
to DJ, level in transgenic mice (13-16).  This suppression, 
however, was found to be less complete as for the TCRfl 
locus. Using mutant # chain genes as transgenes it was shown 
that only the membrane form of/x (/Zm) could suppress rear- 
rangement of endogenous H  chain genes, not the secretory 
form of #  (/xs) (17-19). These findings suggest an active, #m" 
dependent mechanism to induce allelic exclusion. However, 
as for the TCR locus, little is known about the molecular 
basis  of this signaling event. 
There are also parallels between the Ig L chain locus and 
the TCRo~ genes, in that allelic exclusion of both loci can 
be established after gene rearrangement. Functional L chain 
genes alone as transgenes were not able to inhibit rearrange- 
ment of endogenous L chain genes, only complete Ig mole- 
cules were able to do so  (20). 
Interestingly the sizes of thymuses of TgVfl2/Vfl8.2 double 
transgenic mice were significantly reduced as compared to 
thymi of normal and TgVfl2 or TgVfl8.2 single transgenic 
mice. The reduction in thymocyte numbers was particularly 
striking at 6 wk-of-age. There are many possible explana- 
tions for this finding. The expression of both transgenes in 
early T cell progenitors could impair differentiation of these 
cells. Alternatively, the expression of two different TCRs on 
the surface of immature thymocytes could interfere with posi- 
tive selection (for instance, if one TCR is MHC class I and 
the other MHC class II restricted) or increase the rate of nega- 
tive selection. These issues  deserve further study. 
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